Breaking News Instant updates and real-time market news.

NVS

Novartis

$86.55

-0.305 (-0.35%)

07:02
10/22/19
10/22
07:02
10/22/19
07:02

Novartis reports Q3 Zolgensma sales of $160M, says launch 'strong'

  • 22

    Oct

  • 28

    Oct

  • 06

    Nov

  • 07

    Dec

NVS Novartis
$86.55

-0.305 (-0.35%)

09/05/19
09/05/19
UPGRADE
Target $107

Outperform
Incyte upgraded to Outperform from Market Perform at JMP Securities
As previously reported, JMP Securities analyst Reni Benjamin assumed coverage of Incyte (INCY) with an upgraded rating of Outperform and a $107 price target. The analyst cites the "solid fundamentals" of the company's multi-billion dollar Jakafi franchise, including its recent approval in steroid refractory acute graft-versus-host disease, which he believes remains under-appreciated by investors. Benjamin is also positive on Incyte's "marquee" partners that include Novartis (NVS) and Eli Lilly (LLY), along with its $1.7B cash position, diverse pipeline, and strong fundamentals.
09/13/19
DBAB
09/13/19
NO CHANGE
DBAB
Hold
Novartis' ofatumumab to be 'strong' competitor to Roche drug, says Deutsche Bank
Deutsche Bank analyst Richard Parkes tells investors in a research note after attending the ECTRIMS conference in Stockholm that data from Novartis' (NVS) ASCLEPIOS trials suggests ofatumumab will be a "strong" competitor for Roche's (RHHBY) Ocrevus in relapsing/remitting multiple sclerosis. Parkes says he expects physicians to view the drugs as having broadly comparable and highly compelling efficacy, with ofatumumab's at-home dosing an attractive option for some patients, suggesting meaningful upside potential to his current 2024E ofatumumab sales of $1.1B and possible risks to his forecasts for Roche's Ocrevus. According to physician feedback, Parkes says the drugs are likely to share a rapidly growing market. Parkes maintains a Hold rating and 90 CHF price target on Novartis shares.
10/08/19
PIPR
10/08/19
NO CHANGE
Target $435
PIPR
Overweight
Piper positive on Regeneron after 'significant let-down' Novartis label
Piper Jaffray analyst Christopher Raymond is "incrementally positive" on Regeneron Pharmaceuticals (REGN) after the FDA approved Novartis' (NVS) Beovu for the treatment of wet age-related macular degeneration. While the approval was anticipated and physician anticipation of the drug has been high, doctors are likely to view the drug's label "as a significant let-down," Raymond tells investors in a research note. The analyst says that with inflammation and immunogenicity rates meaningfully higher than Regeneron's Eylea, and the lack of flexibility to dose more frequently, he sees little reason for doctors to switch. And while some investors may point to price as another meaningful lever, off-label Avastin makes for an "insurmountable bar for the price-sensitive segment," says Raymond. He keeps an Overweight rating on Regeneron shares with a $435 price target. The label "renders Beovu as little more than an also-ran," contends the analyst. As such, Raymond thinks Eylea's dominance in remains intact.
10/15/19
BOFA
10/15/19
NO CHANGE
BOFA
Europe 1 List changes at BofA/Merrill
BofA/Merrill added Roche (RHHBY) and Sanofi (SNY) to the Europe 1 List and removed AstraZeneca.

TODAY'S FREE FLY STORIES

WBS

Webster Financial

$47.96

0.08 (0.17%)

09:14
11/20/19
11/20
09:14
11/20/19
09:14
Conference/Events
Webster Financial management to meet with Wedbush »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

URBN

Urban Outfitters

$28.73

-1.43 (-4.74%)

09:14
11/20/19
11/20
09:14
11/20/19
09:14
Recommendations
Urban Outfitters analyst commentary  »

Urban Outfitters price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

LOW

Lowe's

$113.41

-1.62 (-1.41%)

09:13
11/20/19
11/20
09:13
11/20/19
09:13
Hot Stocks
Lowe's says saw 'consistent growth across the business' in Q3 »

Says: Focus on Pro…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

UPS

UPS

$120.54

-2.265 (-1.84%)

09:13
11/20/19
11/20
09:13
11/20/19
09:13
Conference/Events
UPS management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

09:12
11/20/19
11/20
09:12
11/20/19
09:12
Conference/Events
World of Business Ideas to hold a forum »

World Business Forum will…

AVB

AvalonBay

$217.04

1.81 (0.84%)

09:11
11/20/19
11/20
09:11
11/20/19
09:11
Recommendations
AvalonBay analyst commentary  »

AvalonBay price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWKS

Skyworks

$96.66

-0.76 (-0.78%)

09:11
11/20/19
11/20
09:11
11/20/19
09:11
Conference/Events
Skyworks management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

SPXC

SPX Corporation

$47.02

-0.35 (-0.74%)

09:08
11/20/19
11/20
09:08
11/20/19
09:08
Conference/Events
SPX Corporation management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 21

    Nov

ZIXI

Zix

$7.31

0.18 (2.52%)

, MCX

MC Shipping

$24.75

(0.00%)

09:06
11/20/19
11/20
09:06
11/20/19
09:06
Conference/Events
Three Part Advisors to hold a conference »

Southwest Ideas…

ZIXI

Zix

$7.31

0.18 (2.52%)

MCX

MC Shipping

$24.75

(0.00%)

VOLT

Volt Information Sciences

$2.73

-0.02 (-0.73%)

CVA

Covanta

$14.65

-0.065 (-0.44%)

PCTI

PCTEL

$8.87

-0.12 (-1.33%)

IVAC

Intevac

$6.00

0.15 (2.56%)

RUBI

Rubicon Project

$7.77

-0.065 (-0.83%)

CHRA

Charah Solutions

$2.32

-0.18 (-7.20%)

TLRA

Telaria

$7.66

-0.18 (-2.30%)

GHM

Graham

$22.60

0.215 (0.96%)

HY

Hyster-Yale Materials

$59.11

1.24 (2.14%)

SDPI

Superior Drilling

$0.88

-0.0355 (-3.87%)

TPB

Turning Point Brands

$25.57

-1.98 (-7.19%)

KLIC

Kulicke & Soffa

$23.19

0.44 (1.93%)

SMTX

SMTC Corp.

$2.85

0.12 (4.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 09

    Dec

  • 12

    Dec

  • 13

    Dec

  • 26

    Feb

SPXC

SPX Corporation

$47.02

-0.35 (-0.74%)

09:06
11/20/19
11/20
09:06
11/20/19
09:06
Conference/Events
SPX Corporation management to meet with Buckingham »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 21

    Nov

STNG

Scorpio Tankers

$32.43

1.28 (4.11%)

09:06
11/20/19
11/20
09:06
11/20/19
09:06
Hot Stocks
Scorpio Tankers announces purchase of call options by company president »

Last night, Scorpio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIDD

Middleby

$114.55

-0.21 (-0.18%)

09:04
11/20/19
11/20
09:04
11/20/19
09:04
Hot Stocks
Middleby acquires Brava Home »

Middleby announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNDM

TNDM

09:04
11/20/19
11/20
09:04
11/20/19
09:04
Hot Stocks
Tandem Diabetes announces Health Canada approval of t:slim X2 pump »

Tandem Diabetes announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEEL

Seelos Therapeutics

$0.87

0.012 (1.39%)

09:03
11/20/19
11/20
09:03
11/20/19
09:03
Hot Stocks
Seelos Therapeutics announces initial dosing of Phase 1 DDI study »

Seelos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

URBN

Urban Outfitters

$28.73

-1.43 (-4.74%)

09:03
11/20/19
11/20
09:03
11/20/19
09:03
Recommendations
Urban Outfitters analyst commentary  »

Urban Outfitters'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

BFC

Bank First National

$68.94

0.67 (0.98%)

09:03
11/20/19
11/20
09:03
11/20/19
09:03
Hot Stocks
Bank First National to acquire Timberwood Bank »

Bank First signed an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$51.69

0.12 (0.23%)

, INSM

Insmed

$20.64

0.54 (2.69%)

09:03
11/20/19
11/20
09:03
11/20/19
09:03
Conference/Events
SVB Leerink to hold a bus tour »

13th Annual POLARxPRESS…

BHVN

Biohaven Pharmaceutical

$51.69

0.12 (0.23%)

INSM

Insmed

$20.64

0.54 (2.69%)

MGNX

MacroGenics

$8.65

0.2 (2.37%)

MRK

Merck

$84.64

0.52 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 07

    Dec

  • 09

    Dec

  • 10

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

SBPH

Spring Bank Pharmaceuticals

$3.23

0.235 (7.86%)

09:02
11/20/19
11/20
09:02
11/20/19
09:02
Hot Stocks
Spring Bank announces dosing of patients in Phase 1 trial of SB 11285 »

Spring Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MUX

McEwen Mining

$1.51

-0.015 (-0.98%)

09:01
11/20/19
11/20
09:01
11/20/19
09:01
Syndicate
McEwen Mining 37.75M share Spot Secondary priced at $1.325 »

Roth Capital and Cantor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

SLRC

Solar Capital

$20.53

0.04 (0.20%)

09:01
11/20/19
11/20
09:01
11/20/19
09:01
Conference/Events
Solar Capital management to meet with Compass Point »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

TGT

Target

$110.86

0.27 (0.24%)

, LOW

Lowe's

$113.41

-1.62 (-1.41%)

09:00
11/20/19
11/20
09:00
11/20/19
09:00
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Aravive (ARAV),…

TGT

Target

$110.86

0.27 (0.24%)

LOW

Lowe's

$113.41

-1.62 (-1.41%)

ARAV

Aravive

$6.69

0.19 (2.92%)

ENDP

Endo

$4.44

-0.02 (-0.45%)

QIWI

Qiwi

$20.14

0.38 (1.92%)

URBN

Urban Outfitters

$28.73

-1.43 (-4.74%)

PAGS

PagSeguro Digital

$36.81

-1.04 (-2.75%)

AVYA

Avaya

$12.11

-0.22 (-1.78%)

PDD

Pinduoduo

$40.71

-0.84 (-2.02%)

QD

Qudian

$5.63

-0.295 (-4.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 03

    Dec

  • 05

    Dec

  • 09

    Dec

  • 17

    Dec

  • 06

    Jul

09:00
11/20/19
11/20
09:00
11/20/19
09:00
General news
U.S. equities are weakening »

U.S. equities are…

DCIX

Performance Shipping

$0.91

0.0001 (0.01%)

08:57
11/20/19
11/20
08:57
11/20/19
08:57
Hot Stocks
Performance Shipping announces agreement to acquire Aframax tanker »

Performance Shipping…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SITE

SiteOne Landscape

$90.15

-0.96 (-1.05%)

08:57
11/20/19
11/20
08:57
11/20/19
08:57
Conference/Events
SiteOne Landscape management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

STI

SunTrust

$70.73

-0.27 (-0.38%)

, BBT

BB&T

$54.71

-0.3 (-0.55%)

08:57
11/20/19
11/20
08:57
11/20/19
08:57
Downgrade
SunTrust, BB&T rating change  »

SunTrust downgraded to…

STI

SunTrust

$70.73

-0.27 (-0.38%)

BBT

BB&T

$54.71

-0.3 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.